| | | | | | | | | | |
|
| |
|
| Dockets Entered
On May 13, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1978N-0036T
|
| Antidiarrheal Drug Products for Over-the-Counter Human Use
|
|
|
|
|
| 1999N-1852
|
| Status reports/postmarketing studies-human drugs&biological
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| 2002D-0113
|
| Root-Form Endosseous Dental Implants and Abutments
|
|
|
|
|
| 2002N-0114
|
| Reclassification of Root-form Endosseous Dental Implants
|
|
|
|
|
| 2004D-0198
|
| Guidance for Industry: Acceptable Full-Length Donor History Questionnaire and Accompanying Materials for Use in Screening Human Donors of Blood and Blood Components
|
|
|
|
|
| 2004P-0227
|
| Adhere to the statutory limitations of section 505(j)(5)(B)(iv) of the Act in issuing final approvals to ANDA applicants
|
|
| |
|
| 1978N-0036T
|
| Antidiarrheal Drug Products for Over-the-Counter Human Use
|
|
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 1999N-1852
|
| Status reports/postmarketing studies-human drugs&biological
|
|
|
|
|
| NAL
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS
2
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| EMC 750
|
| John Heath
|
| Vol #:
|
| 271
|
|
|
|
|
| EMC 751
|
| Susan StPeter
|
| Vol #:
|
| 271
|
|
|
|
|
| 2002D-0113
|
| Root-Form Endosseous Dental Implants and Abutments
|
|
|
|
|
| GDL
2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2002N-0114
|
| Reclassification of Root-form Endosseous Dental Implants
|
|
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0198
|
| Guidance for Industry: Acceptable Full-Length Donor History Questionnaire and Accompanying Materials for Use in Screening Human Donors of Blood and Blood Components
|
|
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0227
|
| Adhere to the statutory limitations of section 505(j)(5)(B)(iv) of the Act in issuing final approvals to ANDA applicants
|
|
|
|
|
| ACK
1
|
| HFA-305 to Wiley Rein & Fielding LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
|
| Wiley Rein & Fielding LLP
|
| Vol #:
|
| 1
|
|
